Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Pilon, Richard ^a   Leonard, Lynne ^b   Kim, John ^a   Vallee, Dominic ^a   de Rubeis, Emily ^b   Jolly, Ann M ^a,b   Wylie, John ^c,d   Pelude, Linda ^a   Sandstrom, Paul ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d CADHAM PROVINCIAL LABORATORY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POL PROTEIN;

ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LOCATION; GENETIC VARIABILITY; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; SERODIAGNOSIS; SOCIAL ENVIRONMENT; SOCIAL NETWORK; UNINDEXED SEQUENCE; VIRUS TRANSMISSION; BLOOD; CLUSTER ANALYSIS; DISEASE TRANSMISSION; DRUG USE; GENETICS; GENOTYPING TECHNIQUE; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; PATHOGENICITY; SEROLOGY;

HEPATITIS C VIRUS;

CLUSTER ANALYSIS; DRUG USERS; FEMALE; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; INJECTIONS; MALE; RISK-TAKING; SEROLOGIC TESTS; SOCIAL NETWORKING;

EID: 79960588574     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022245     Document Type: Article

References (21)

1. UNAIDS (2008) Report on the global HIV/AIDS epidemic 2008. Available: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp.
2. Mathers B, Degenhardt L, Phillips B, Wiessing L, Hickman M, et al. (2008) Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372: 1733-45.
3. McMahon J, Pouget E, Tortu S, (2007) Individual and Couple-Level Risk Factors for Hepatitis C Infection among Heterosexual Drug Users: A Multilevel Dyadic Analysis. J Infect Dis 195: 1572-81.
4. Public Health Agency of Canada. (2007) HIV/AIDS Epi Updates, November 2007. Available: http://www.phac-aspc.gc.ca/aids-sida/publication/epi/pdf/epi2007_e.pdf.
5. Public Health Agency of Canada (2007) Modelling the Incidence and Prevalence of Hepatitis C Infections and its Sequelae in Canada, 2007. Available: http://www.phac-aspc.gc.ca/sti-its-surv-epi/model/pdf/model07-eng.pdf.
6. Millson P, Leonard L, Remis R, Strike C, Challacombe L, (2005) Injection drug use, HIV and HCV infection in Ontario: The evidence 1992 to 2004. Availabl:http://www.health.gov.on.ca/english/providers/pub/aids/reports/injection_druguse_hiv_hcv_infection_ontario_evi.pdf.
7. Heckathorn D, (1997) Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems 44: 174-199.
8. Magnani R, Sabin K, Saidel T, Heckathorn D, (2005) Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 19: S67-S72.
9. Batagelj V, Mrvar A, (2002) Pajek - Analysis and Visualization of Large Networks. Lecture Notes in Computer Science 2265: 8-11.
10. Boom R, Sol C, Salimans M, Jansen C, Wertheim-van Dillen P, et al. (1990) Rapid and simple method for purification of nucleic acids. J Clin Micro 28: 495-503.
11. WHO Manual for HIV Drug Resistance Testing Using Dried Blood Spots (March, 2010) Available: http://www.who.int/hiv/topics/drugresistance/dbs_protocol.pdf.
12. Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, et al. (2010) Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 52: 1564-72.
13. Larkin M, Blackshields G, Brown N, Chenna R, McGettigan P, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-8.
14. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evol 24: 1596-99.
15. Fitzgibbon J, Gaur S, Frenkel L, Laraque F, Edlin B, et al. (1993) Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med 329: 1835-41.
16. Yirrell D, Robertson P, Goldberg D, McMenamin J, Cameron S, et al. (1997) Molecular investigation into outbreaks of HIV in Scottish Prison. BMJ 314: 1446.
17. Brooks J, Robbins K, Youngpairoj A, Rotblatt H, Kerndt P, et al. (2006) Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004. AIDS 20: 923-8.
18. Bernard E, Azad Y, Vandamme AM, Weait M, Geretti AM, (2007) HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission. HIV Medicine 8: 382-7.
19. Aitken C, McCaw R, Bowden D, Tracy S, Kelsall F, et al. (2004) Molecular Epidemiology of Hepatitis C Virus in a Social Network of Injection Drug Users. JID 190: 1586-95.
20. Smyth B, Keenan E, O'Connor J, (1998) Bloodborne viral infection in Irish injecting drug users. Addiction 93: 1649-56.
21. Lee S, (2009) Prevalence of hepatitis C infection in Injection Drug Users in Hong Kong. Hong Kong Med J 15 (Suppl 8): S45-6.